Form D · Pharmaceuticals
60 DEGREES PHARMACEUTICALS, INC.
Washington, DC · CIK 0001946563
Offering snapshot reported Feb 12, 2025 · SEC filing
- Reported sold
- $1.08M Offering amount: $1.08M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2025 | Initial | $1,075,003 | No comparison | 4 | SEC filing |
| Feb 11, 2025 | Initial | $1,043,002 | No comparison | 4 | SEC filing |
| May 24, 2023 | Initial | $1,755,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $91.4K (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-537991
Includes a 1.0% cash fee on gross proceeds from the registered shares paid to HC Wainwright. No separate commission was charged for the warrants, but the fee may be attributed to the private placement of the warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C.WAINWRIGHT & CO., LLC | 375 |
Source: Form D, filed Feb 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Geoffrey S. Dow | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1025 Connecticut Avenue Nw Suite 1000
Washington, DC, 20036
Washington, DC, 20036